Literature DB >> 7590431

Effect of intestinal resection on serum antibodies to the mycobacterial 45/48 kilodalton doublet antigen in Crohn's disease.

G Kreuzpaintner1, P K Das, A Stronkhorst, A W Slob, G Strohmeyer.   

Abstract

Interest in the role of mycobacterial infection in Crohn's disease has been revived by the cultural detection of Mycobacterium paratuberculosis in patients with Crohn's disease. This hypothesis was examined serologically using assays with high specificity for Crohn's disease. The effect of intestinal resection on serum antibodies specific for Crohn's disease was investigated with an immunoblot assay and an enzyme linked immunosorbent assay using the 45/48 kilodalton doublet antigen of Mycobacterium tuberculosis. Antibodies were detected in 64.7% of patients with Crohn's disease (n = 17), 10% of patients with ulcerative colitis (n = 10), 5% of patients with carcinoma of the colon (n = 20), and none of 10 healthy subjects with the immunoblot assay. Statistical comparison of the Crohn's disease patients with each control group resulted in p = 0.0000236. Immunoglobulin G was essentially unchanged 75 days (mean) after surgery. After more than 180 days, however, the antibody response was reduced in all of five patients studied, and was no longer demonstrable in two of them (40%). Simultaneously, the Crohn's disease activity index (CDAI) decreased. Both the high specificity of this assay for Crohn's disease and the diminished antibody response after intestinal resection in parallel with decreased CDAI support a mycobacterial aetiology of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590431      PMCID: PMC1382816          DOI: 10.1136/gut.37.3.361

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  21 in total

1.  Mycobacterium paratuberculosis DNA in Crohn's disease tissue.

Authors:  J D Sanderson; M T Moss; M L Tizard; J Hermon-Taylor
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Further data on skin testing with mycobacterial antigens in inflammatory bowel disease.

Authors:  P R Elliott; J E Lennard-Jones; W R Burnham; S White; J L Stanford
Journal:  Lancet       Date:  1980-08-30       Impact factor: 79.321

5.  Skin test reactivity in inflammatory bowel disease in the United States and Czechoslovakia.

Authors:  W R Thayer; B Fixa; O Komarkova; C Charland; C E Field
Journal:  Am J Dig Dis       Date:  1978-04

6.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

7.  Subcellular distribution of monoclonal antibody defined epitopes on immunodominant Mycobacterium tuberculosis proteins in the 30-kDa region: identification and localization of 29/33-kDa doublet proteins on mycobacterial cell wall.

Authors:  A Rambukkana; P K Das; A Chand; J G Baas; D G Groothuis; A H Kolk
Journal:  Scand J Immunol       Date:  1991-06       Impact factor: 3.487

8.  Antibodies to Mycobacterium paratuberculosis and nine species of environmental mycobacteria in Crohn's disease and control subjects.

Authors:  K J Stainsby; J R Lowes; R N Allan; J P Ibbotson
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

9.  Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA and IgM classes in tuberculosis, sarcoidosis and Crohn's disease.

Authors:  J M Grange; J Gibson; E Nassau; T Kardjito
Journal:  Tubercle       Date:  1980-09

10.  Agglutinins to bacteria in Crohn's disease.

Authors:  N Matthews; J F Mayberry; J Rhodes; L Neale; J Munro; F Wensinck; G H Lawson; A C Rowland; G A Berkhoff; S W Barthold
Journal:  Gut       Date:  1980-05       Impact factor: 23.059

View more
  2 in total

Review 1.  Anti-TNF antibody treatment of Crohn's disease.

Authors:  S J van Deventer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  The role of the microbiome in rheumatic diseases.

Authors:  Nigel Yeoh; Jeremy P Burton; Praema Suppiah; Gregor Reid; Simon Stebbings
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.